Anti-inflammatory function of arctiin by inhibiting COX-2 expression via NF-κB pathways
© Lee et al; licensee BioMed Central Ltd. 2011
Received: 17 June 2010
Accepted: 7 July 2011
Published: 7 July 2011
Arctiin, isolated from Forsythia suspensa has been reported to have anti-inflammatory, anti-oxidant, antibacterial, and antiviral effects in vitro. However, there has been a lack of studies regarding its effects on immunological activity. The aim of this study is to investigate the anti-inflammatory potential and possible mechanisms of arctiin in LPS-induced macrophages.
We investigated the mRNA and protein levels of proinflammatory cytokines through RT-PCR and western blot analysis, followed by a FACS analysis for surface molecule changes.
Arctiin dose dependently decreased the production of NO and proinflammatory cytokines such as IL-1β, IL-6, TNF-α, and PGE2, and it reduced the gene and protein levels as determined by RT-PCR and western blot analysis, respectively. The expression of co-stimulatory molecules such as B7-1 and B7-2 were also inhibited by arctiin. Furthermore, the activation of the nuclear transcription factor, NF-κB in macrophages was inhibited by arctiin.
Taken together these results provide evidence of the bioactivity of arctiin in inflammatory diseases and suggest that arctiin may exert anti-inflammatory effect by inhibiting the pro-inflammatory mediators through the inactivation of NF-kB.
Non-steroidal anti-inflammatory drugs (NSAIDs) have been widely used in the treatment of acute and chronic inflammatory diseases, which play their therapeutic effects via inhibiting cyclooxygenase (COX) to prevent the production of pro-inflammatory prostaglandins. However, their long-term use shows the major side-effects of gastrointestinal diseases. Thus researchers have tried to screen new biological components from various plant sources including medicinal plants which inhibited COX with lower toxicity and higher anti-inflammatory activity on the great deal in the therapeutic application .
Chronic inflammation and infection has been demonstrated to lead to an upregulation of a series of enzymes and signaling proteins in affected tissues and cells. Inflammation has been shown to be a multi-step process, mediated by activated inflammatory and immune cells including macrophages and monocytes . Inflammatory reactions, phagocytosis, natural cytotoxicity, cytokine production, antibody response, and cellular immunity are defensive mechanisms that have been suggested to be modulated by therapeutic doses of antimicrobial agents . Activated macrophages include the inducible forms of nitric oxide synthase (iNOS) and cyclooxygenase-2 (COX-2), which have been reported to be responsible for increasing the levels of nitric oxide (NO) and prostaglandins (PGs), the overproduction of proinflammatory cytokines (e.g. TNF-α, IL-6, IL-1β) and inflammatory mediators (e.g. PGE2, NO), and the mediation of many inflammatory diseases .
Costimulatory molecules are one class of receptors, which have recently been implicated as fulfilling this role in the innate immune response. B7-1 and -2 represent one class of costimulatory receptors. They consist of structurally related, cell-surface protein ligands, which bind to receptors on lymphocytes that regulate immune responses. In addition, they are stimulated via CD28 while CTLA4 serves as both a stoichiometric inhibitor of CD28-B7-1/-2 engagement as well as serving to directly induce immunosuppressive signals within dendritic cells .
In this study, we evaluated the potential of arctiin as a therapeutic modality for inflammation in RAW264.7 mouse macrophage cells as well as in primary peritoneal macrophages. Our results demonstrated that arctiin largely inhibited the excessive production of inflammatory mediators such as NO, PGE2, TNF-α, IL-1β and IL-6 as well as the suppression of COX-2 through the inhibition of NF-kB translocation pathway.
Chemicals and reagents
Dulbecco's Modified Eagle Medium (DMEM)-1640, fetal bovine serum (FBS), and penicillin/streptomycin were purchased from Hyclone (Logan, USA). Escherichia coli lipopolysaccharide (LPS) was purchased from sigma (St. Louis, USA). β-actin, i-NOS, COX-2, p65, p-IκBα, PE-B7-1, and FITC-B7-2 anti-bodies were purchased from BD Pharmingen™ (San Jose, USA). Enzyme immunoassay kits for the measurement of PGE2, IL-1β, IL-6, and TNF-α were purchased from R&D system (Minneapolis, USA).
Isolation of arctiin from Forsythiae Fructus
Forsythiae Fructus obtained from an herbal market in Seoul, Korea, was extracted three times with hot MeOH (3 hours) and then evaporated at 40°C under reduced pressure to dryness. The MeOH extract was then resuspended in distilled water and successively partitioned with CHCl3, EtOAc, and n-BuOH. The BuOH fraction was then loaded onto a silica gel column and eluted with MeOH-CHCl3 mixtures (1:5 to 1:1). The result was white amorphous powders, which were identified as authentic samples using spectrometric data of nuclear magnetic resonance (1H-NMR), mass spectrometry (MS). 1H-NMR (300 MHz), DMSO-d6 : δ 6.97(1H, d, J = 8.3, H-5), 6.82 (1H, d, J = 8.0, H-5'), 6.77 (1H, d, J = 1.7, H-2), 6.65 (1H, dd, J = 8.3, 1.7, H-6), 6.65 (1H, s, H-2'), 6.59 (1H, dd, J = 8.0, 1.8, H-6'), 4.83 (1H, d, J = 7.3, H-1''), 4.00 (2H, m, H-9'), 3.70 (3H, s, OCH3), 3.69 (6H, s, OCH3), 2.76 (2H, m, H-7'), 2.54 (4H, m, H-7, 8, 8'). Positive FABMS (m/z): 557 (M + Na+), 372 (M + gluco), 154, 136. The white amorphous powder compound analyzed by NMR and MS was identified to arctiin (Figure 1A).
ICR mice (6-8 weeks old, specific pathogen-free) were obtained from Orient-Bio Co. (Seongnam, Korea). Animals were fed with standard laboratory chow (PMI Lab Diet, Richmond, USA) and autoclaved distilled water (DW). They were acclimatized in an animal facility (Sahmyook University, Korea) and maintained at 22 ± 2°C in 50 ± 10% relative humidity and a light/dark (12 hrs/12 hrs) cycle for at least 7 days prior to the experiments.
Male ICR mice (6-8 weeks) were intraperitoneally injected with 1.5 ml thioglycollate broth for recruitment of macrophages. RAW 264.7 cells were obtained from the American Type Culture Collection (ATCC, Rockville, USA). These cells were grown at 37°C in DMEM medium supplemented with 10% FBS and 1% (v/v) penicillin (10,000 U/ml)/streptomycin (10,000 U/ml) in a humidified 5% CO2-95% air incubator under standard conditions.
Cell viability assay
A commercially available cell viability assay was employed to evaluate the cytotoxic effect of arctiin using thiazolyl blue tetrazolium bromide (SIGMA, USA). RAW264.7 cells (2 × 105 cells/well) were plated with various concentrations of arctiin in 96-well microtiter plates (Nunc, Roskilde, Denmark) and were then cultured at 37°C in a 5% CO2 incubator. Subsequently, 50 μl of MTT solution was added to each well, and the cells were then cultured for 4 hrs at 37°C in the same incubator. Following this, 100 μl of solubilized solution were added to each well and the plate was allowed to stand overnight in the incubator. The optical density (OD) was then measured at 560 nm by a microplate reader (Molecular devices, USA).
RAW 264.7 cells were added to each well (200 μl; 1 × 106 cells/ml) of a flat-bottomed 96-well plate according to the following treatment condition: LPS (100 ng/ml), LPS/arctiin (12.5, 25, 50, 100 μg/ml), and media only (DMEM-10). Nitric oxide was measured in culture supernatants by reaction with the Griess reagent (1% sulfanilamide and 0.1% N-[1-naphthy]-ethylenediamine dihydrochloride in 5% phosphoric acid; Roche) to 100 μl of culture supernatant for 15 min at room temperature in the dark. The absorbance at 540 nm was then determined using a microplate reader (Molecular devices, USA) and a standard curve was generated using NaNO2.
Determination of pro-inflammatory cytokines and PGE2
RAW 264.7 cells and primary macrophages were cultured in 12-well flat plates at a density of 5 × 106 cells/well. The cells were then treated with various concentrations of arctiin and subsequently stimulated with LPS (100 ng/ml) at 37°C for 48 hrs in humidified air with 5% CO2. The supernatants were then collected and measured for TNF-α, IL-1β, IL-6, and PGE2 by an enzyme-linked immunosorbent assay (ELISA) according to the manufacturer's protocol.
RT-PCR (reverse transcription polymerase chain reaction)
Total RNA was extracted from macrophages using the RNeasy Mini Kit (QIAGEN, USA) in an RNase-free environment. The reverse transcription of 1 μg RNA was carried out using M-MLV reverse transcriptase (Promega, USA), oligo (dT) 16 primer, dNTP (0.5 mM) and 1 U RNase inhibitor. After incubation at 65°C for 5 min and 37°C for 60 min, M-MLV reverse transcriptase was inactivated by heating at 70°C for 15 min. The polymerase chain reaction (PCR) was performed in 50 mM KCl, 10 mM Tris-HCl (pH8.3), 1.5 mM MgCl2, and 2.5 mM dNTPs with 5 units of Taq DNA polymerase and 10 pM of each primer set for IL-1β, IL-6, TNF-α, iNOS, and COX-2. The cDNA was amplified by 35 cycles of denaturing at 94°C for 45 s, annealing at 60°C for 45 s, and extension at 72°C for 1 min. Final extension was performed at 72°C for 5 min. The PCR products were electrophoresed on 1.5% agarose gels and stained with ethidium bromide. The primer sequences were as follows: 5'- AGC TCC TCC CAG GAC CAC AC-3' (forward), 5'-ACG CTG AGT ACC TCA TTG GC-3' (reverse) for i-NOS, 5'-AAG AAG AAA GTT CAT TCC TGA TCC C-3' (forward), 5'-TGA CTG TGG GAG GAT ACA TCT CTC-3' (reverse) for COX-2, and 5'-GTG GGC CGC CCT AGG ACC AG-3' (forward), 5'- GGA GGA AGA GGA TGC GGC AG T-3' (reverse) for β-actin as a control for PCR. The band intensity was quantified by densitometric analysis (Infinity 3026, Vilber Lourmat, France).
Preparation of cytosolic and nuclear extracts
The cells were collected after culture and washed twice with cold PBS, resuspended in hypotonic buffer (10 mM HEPES, pH 7.9, 10 mM KCl, 1.5 mM MgCl2, 0.2 mM PMSF, 0.5 mM DTT, 10 μg/ml aportinin). After 15 min incubation on ice, the cells were lysed by the addition of 0.1% NP-40 and vigorous vortexing for 1 min. The nuclei were pelleted by centrifugation at 12,000 × g for 1 min at 4°C and resuspended in high salt buffer (20 mM HEPES, pH 7.9, 25% glycerol, 400 mM KCl, 1.5 mM MgCl2, 0.2 mM EDTA, 0.5 mM DTT, 1 mM NaF, 1 mM sodium orthovanadate). The cytosolic and nuclear extracts were stored in aliquots at -70°C.
Western blot analysis
RAW264.7 cells were washed with phosphate-buffered saline (PBS) and lysed using lysis buffer (1% SDS, 1.0 mM sodium vanadate, 10 mM Tris-Cl buffer, pH 7.4) for 5 min. Further, 20 μg of protein from the cell lysates were applied to 8-12% SDS-polyacrylamide gels and then transferred to nitrocellulose membranes. The membranes were blocked in 5% skim milk solution for 1 h. They were then incubated with anti-TNF-α, anti-IL-1β, anti-IL-6, anti-iNOS, anti-COX-2, anti-p-IκBα, or anti-p65 monoclonal antibodies for 2 h and subsequently washed 3 times with PBS. After incubation with an AP-labeled secondary antibody for 2 h, the bands were visualized using an alkaline phosphatase substrate (VECTOR, USA).
RAW 264.7 cells (1 X 106 cells/ ml) were cultured in Petri-dishes. The cells were treated with various concentrations (12.5, 25, 50, 100 μg/ ml) of arctiin in the presence of LPS (100 ng/ ml). The dishes were incubated at 37°C for overnight in humidified 5% CO2 incubator under standard conditions. The cells were then washed with PBS. The washed cells were blocked with staining buffer containing 10% normal mouse serum (NMS) for 20 min on ice. The blocked cells were incubated with co-stimulatory molecules such as B7-1 and B7-2 antibody (BD Biosciences, San Jose, USA) for 20 min on ice. The incubated cells were washed three times with staining buffer and then fixed by 1% paraformaldehyde in PBS. The fixed cells were measured by flow cytometry (Beckman coulter, Brea, USA).
All data are presented as mean ± SEM values. Significant differences (P < 0.05) between groups were evaluated using a one-way analysis of variance with SPSS (Chicago, IL, USA) for Windows and Duncan's Multiple Range Test where appropriate.
Prior to evaluating whether arctiin showed anti-inflammatory activity, we examined its effect on cell growth in RAW264.7 cells and found that arctiin did not affect normal cell growth at concentrations up to 100 μg/ml (Figure 1B). Thus, in the following experiments, arctiin was studied at concentrations up to 100 μg/ml in order to exclude any effects on the normal growth status of cells.
Effect of arctiin on PGE2 and NO production in macrophages
Arctiin down-regulates production of pro-inflammatory cytokines
Effect of arctiin on the expression of co-stimulatory molecules
Effect of arctiin on the activation of NF-κB
Arctiin is lignin compound isolated from Forsythiae Fructus. The anti-cancer [3, 7, 8] and platelet activating factor antagonistic effects  of arctiin have been well documented but the mechanisms underlying anti inflammatory effect are still not understood. The present study found that arctiin significantly inhibited the effects of LPS by suppressing a key inflammatory pathway related to NF-κB, PGE2 and NO production, and pro-inflammatory cytokines expression.
Inflammation is a reaction of the body to injury or to infectious, allergic, or chemical irritation. Leukocytes destroy harmful microorganisms and dead cells, preventing the spread of the irritation and permitting the injured tissue to repair itself. However, excessive or persistent inflammation causes a variety of pathological conditions, such as bacterial septic shock, and rheumatoid arthritis [18, 19]. Inflammatory mediators (e.g. nitric oxide and pro-inflammatory cytokines) have been demonstrated to be critically involved in the development of inflammatory diseases.
Macrophages play important roles in regulating cell-mediated immune responses, such as adaptive immune, innate immune, and allergic reactions, as well as inflammation in response to microbes and microbial products such as LPS . In addition to the well-known function of endocytosis, macrophages can be induced to secrete nitric oxide and a series of cytokines including TNF-α, IL-1β, IL-6, and IL-12 that express NF-κB-dependent i-NOS [21, 22] and COX-2 . Many diseases, such as arteriosclerosis, chronic hepatitis and pulmonary fibrosis, involve the overproduction of inflammatory mediators [24–27] and thus, inhibiting their production may serve to prevent or suppress a variety of inflammatory diseases, including rheumatoid arthritis (RA), sepsis, and endotoxemia. Despite the exact cause of autoimmune disease remaining obscure, deregulated overproduction of pro-inflammatory cytokines and a disruption in the regulation of cytokine signal transduction have been indicated as underlying mechanisms of some autoimmune diseases such as RA and Crohn's disease [28, 29].
Nitric oxide is synthesized via the oxidation of arginine by a family of NOS, and it plays a vital role in regulating physiological processes, such as blood vessel tone and neurotransmission, as well as in host defense and immunity [30, 31]. Pro-inflammatory cytokines, IL-1β, IL-6, and TNF-α, have attracted more attention in that they can be localized to the infected tissue, manifested systemically throughout the body, and cause vasodilation as well as symptoms of inflammation [32–34]. Our findings that arctiin inhibits the formation of NO and pro-inflammatory cytokines showed the importance of arctiin as an anti-inflammatory compound. The reduced NO production by arctiin was a consequence of an inhibition of iNOS, the key enzyme responsible for NO production under pathological conditions.
PGE2 plays major roles in the angiogenesis of synovium through the expression of vascular endothelial growth factors , synovial inflammation, and joint erosion in RA . Further, in the prostaglandin biosynthesis pathway, COX-2 is the key enzyme that catalyzes the conversion of arachidonic acid to PGE2. It is generally accepted that PGE2 is produced by COX-2 at sites of inflammation, and that COX-1, another constitutive isoform, is relevant in the production of prostaglandins that regulate normal cellular processes such as vascular homeostasis regulation, gastric mucosal protection and renal integrity maintenance . In the present study, we found that arctiin suppressed PGE2 production via inhibition of COX-2 enzyme activity and this may in part be responsible for some of anti-inflammatory properties of this compound.
The transcriptional factor NF-κB is important for the expression of immune and inflammatory genes. The activated NF-κB then binds κB motifs in the promoters via its p65 subunit, leading to expression of several inflammatory genes. Because NF-κB transcription factors are uniquely positioned downstream of multiple innate and adaptive signaling pathways, they seem ideally placed to integrate and coordinate innate and adaptive signals required for formation of productive immune responses. In the present study, we found that arctiin could inhibit the NF-κB nucleus translocation induced by LPS through a reduction in IκB phosphorylation status.
The B7 family is related immunoglobulin supergene family members that are expressed by multiple cell types involved in antigen presentation. Both B7-1 and B7-2 are constitutively expressed on dendritic cells and are regulated on monocytes, macrophages, B cells, and T cells following activation. In agreement with our findings, arctiin has also been shown to suppress co-stimulatory molecules such as B7-1 and B7-2 in macrophages.
In summary, these results suggest that arctiin has anti-inflammatory effects on macrophages through the reduced pro-inflammatory cytokines are associated with NF-κB inactivation and the suppression of NF-kB-regulated proteins, and other bioactive substances as well as through inhibition of the expression of co-stimulatory molecules.
This study was supported by the Sahmyook University Research fund in 2010.
- Lee GI, Ha JY, Min KR, Nakagawa H, Tsurufuji S, Chang IM: Inhibitory effects of oriental herbal medicines on IL-8 induction in lipopolysaccharide-activated rat macrophages. Planta Med. 1995, 61 (1): 26-30. 10.1055/s-2006-957992.PubMedView Article
- Kim TJ: Korean resources plants. 1991, Seoul, first
- Huang DM, Shen YC, Wu C, Huang YT, Kung FL, Teng CM, Guh JH: Investigation of extrinsic and intrinsic apoptosis pathways of new clerodane diterpenoids in human prostate cancer PC-3 cells. Eur J Pharmacol. 2004, 503 (1-3): 17-24. 10.1016/j.ejphar.2004.09.040.PubMedView Article
- Macrae WD, Tower GH: Biological activities of Lignans. Phytochemistry. 1984, 23: 1207-1220. 10.1016/S0031-9422(00)80428-8.View Article
- Morita K, Nishijima Y, Kada T: Chemical nature of a desmutagenic factor from Burdock (Arctium lappa Linne). Agr Biol Chem. 1985, 49: 925-932.View Article
- Kazuki S, Seikichi K, Misao M, Zwe-Ling K, Hiroshi H: Antimutagenicity of Dialyzates of Vegetables and Fruits (Food & Nutrition). Agr Biol Chem. 1988, 52: 1369-1375.View Article
- Ryu S, Ahn J, Kang Y, Han B: Antiproliferative effect of arctigenin and arctiin. Arch Pharmacol Res. 1995, 18: 462-463. 10.1007/BF02976353.View Article
- Moritani S, Nomura M, Takeda Y, Miyamoto K: Cytotoxic components of bardanae fructus (goboshi). Biol Pharm Bull. 1996, 19: 1515-1517.PubMedView Article
- Iwakami S, Wu JB, Ebizuka Y, Sankawa U: Platelet activating factor (PAF) antagonists contained in medicinal plants: lignans and sesquiterpenes. Chem Pharm Bull. 1992, Tokyo, 40: 1196-1198.
- Ichikawa K, Kinoshita T, Nishibe S, Sankawa U: The Ca2+ activity of lignans. Chem Pharm Bull. 1986, 34: 3514-3517.PubMedView Article
- Liu S, Chen K, Schliemann W, Strack D: Isolation and identification of arctiin and arctigenin in leaves of burdock (Arctium lappa L.) by polyamide column chromatography in combination with HPLC-ESI [sol] MS. Phytochem Anal. 2005, 16: 86-89. 10.1002/pca.816.PubMedView Article
- Minagar A, Shapshak P, Fujimura R, Ownby R, Heyes M, Eisdorfer C: The role of macrophage/microglia and astrocytes in the pathogenesis of three neurologic disorders: HIV-associated dementia, Alzheimer disease, and multiple sclerosis. J Neurol Sci. 2002, 202: 13-23. 10.1016/S0022-510X(02)00207-1.PubMedView Article
- Stevens DL: Immune modulatory effects of antibiotics. Curr Opin Infec Dis. 1996, 9: 165-169. 10.1097/00001432-199606000-00007.View Article
- Nathan C: Nitric oxide as a secretory product of mammalian cells. FASEB J. 1992, 6: 3051-3064.PubMed
- Sharpe AH, Freeman GJ: The B7-CD28 superfamily. Nat Rev Immunol. 2002, 2: 116-126. 10.1038/nri727.PubMedView Article
- Gomez PF, Pillinger MH, Attur M, Marjanovic N, Dave M, Park J: Resolution of inflammation: prostaglandin E2 dissociates nuclear trafficking of individual NF-kappaB subunits (p65, p50) in stimulated rheumatoid synovial fibroblasts. J Immunol. 2005, 175: 6924-6930.PubMedView Article
- Strayhorn WD, Wadzinski BE: A novel in vitro assay for deubiquitination of I kappa B alpha. Arch Biochem Biophys. 2002, 400: 76-84. 10.1006/abbi.2002.2760.PubMedView Article
- Dinarello C: Proinflammatory and anti-inflammatory cytokines as mediators in the pathogenesis of septic shock. Chest. 1997, 112: 321S-329S. 10.1378/chest.112.6_Supplement.321S.PubMedView Article
- Palladino M, Bahjat F, Theodorakis E, Moldawer L: Anti-TNF-alpha therapies: the next generation. Nat Rev Drug Discov. 2003, 2: 736-746. 10.1038/nrd1175.PubMedView Article
- Firestein GS: Invasive fibroblast-like synoviocytes in rheumatoid arthritis. Passive responders or transformed aggressors?. Arthritis Rheum. 1996, 39: 1781-1790. 10.1002/art.1780391103.PubMedView Article
- Nathan C: Inducible nitric oxide synthase: what difference does it make?. J Clin Invest. 1997, 100: 2417-2423. 10.1172/JCI119782.PubMedPubMed CentralView Article
- Bogdan C: Nitric oxide and the immune response. Nat Immunol. 2001, 2: 907-916.PubMedView Article
- Vila-del Sol V, Fresno M: Involvement of TNF and NF-kappa B in the transcriptional control of cyclooxygenase-2 expression by IFN-gamma in macrophages. J Immunol. 2005, 174: 2825-2833.View Article
- Isomaki P, Punnonen J: Pro- and anti-inflammatory cytokines in rheumatoid arthritis. Ann Med. 1997, 29: 499-507. 10.3109/07853899709007474.PubMedView Article
- Libby P, Ridker P, Maseri A: Inflammation and atherosclerosis. Am Heart Assoc. 2002, 150: 1135-1143.
- Tilg H, Wilmer A, Vogel W, Herold M, Nolchen B, Judmaier G: Serum levels of cytokines in chronic liver diseases. Gastroenterology. 1992, 103: 264-274.PubMed
- Coker RK, Laurent GJ: Pulmonary fibrosis: cytokines in the balance. Eur Respir J. 1998, 11: 1218-1221. 10.1183/09031936.98.11061218.PubMedView Article
- Chenevier-Gobeaux C, Morin-Robinet S, Lemarechal H, Poiraudeau S, Ekindjian JC, Borderie D: Effects of pro- and anti-inflammatory cytokines and nitric oxide donors on hyaluronic acid synthesis by synovial cells from patients with rheumatoid arthritis. Clin Sci (Lond). 2004, 107: 291-296. 10.1042/CS20040104.View Article
- Nishimoto N: Cytokine signal regulation and autoimmune disorders. Autoimmunity. 2005, 38: 359-367. 10.1080/08916930500124106.PubMedView Article
- Furchgott R, Cherry P, Zawadzki J, Jothianandan D: Endothelial cells as mediators of vasodilation of arteries. J Cardiovasc Pharmacol. 1984, 6: S336-343.PubMedView Article
- Wei X, Charles I, Smith A, Ure J, Feng G, Huang H: Altered immune responses in mice lacking inducible nitric oxide synthase. Nature. 1995, 375: 408-4011. 10.1038/375408a0.PubMedView Article
- Haddad JJ, Safieh-Garabedian B, Saadé NE, Kanaan SA, Land SC: Chemioxyexcitation (delta pO2/ROS)-dependent release of IL-1 beta, IL-6 and TNF-alpha: evidence of cytokines as oxygen-sensitive mediators in the alveolar epithelium. Cytokine. 2001, 13: 138-147. 10.1006/cyto.2000.0789.PubMedView Article
- Moldoveanu A, Shephard R, Shek P: Exercise elevates plasma levels but not gene expression of IL-1β, IL-6, and TNF-α in blood mononuclear cells. J Appl Physiol. 2000, 89: 1499-1504.PubMed
- Ben-Av P, Crofford L, Wilder R, Hla T: Induction of vascular endothelial growth factor expression in synovial fibroblasts by prostaglandin E and interleukin-1: a potential mechanism for inflammatory angiogenesis. FEBS Lett. 1995, 372: 83-87. 10.1016/0014-5793(95)00956-A.PubMedView Article
- Dayer J: Prostaglandin production by rheumatoid synovial cells: stimulation by a factor from human mononuclear Cells. J Exp Med. 1977, 145: 1399-1404. 10.1084/jem.145.5.1399.PubMedView Article
- Lecomte M, Laneuville O, Ji C, DeWitt D, Smith W: Acetylation of human prostaglandin endoperoxide synthase-2 (cyclooxygenase-2) by aspirin. J Biol Chem. 1994, 269: 13207-13215.PubMed
- Vane J, Bakhle Y, Botting R: Cyclooxygenases 1 and 2. Annu Rev Pharmacol Toxicol. 1998, 38: 97-120. 10.1146/annurev.pharmtox.38.1.97.PubMedView Article
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.